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The biological eﬀects of only a ﬁnite number of tobacco toxins have been studied. Here, we describe exposure of cultures
of human bronchial epithelial cells to low concentrations of tobacco carcinogens: nickel sulphate, benzo(b)ﬂuoranthene,
N-nitrosodiethylamine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). After a 24-hour exposure, EGFR was
expressed in cell membrane and cytoplasm, BCL-2 was expressed only in the irregular nuclei of large atypical cells, MKI67 was
expressed in nuclei with no staining in larger cells, cytoplasmic BIRC5 with stronger nuclear staining was seen in large atypical
cells, and nuclear TP53 was strongly expressed in all cells. After only a 24-hour exposure, cells exhibited atypical nuclear and
cytoplasmic features. After a 48-hour exposure, EGFR staining was localized to the nucleus, BCL-2 was slightly decreased in
intensity, BIRC5 was localized to the cytoplasm, and TP53 staining was increased in small and large cells. BCL2L1 was expressed in
boththecytoplasmandnucleiofcells at24-and48-hourexposures.We illustratethatshort-termexposureofabronchialepithelial
cell line to smoking-equivalent concentrations of tobacco carcinogens alters the expression of key proliferation regulatory genes,
EGFR,BCL-2,BCL2L1,BIRC5,TP53,andMKI67,similartothatreportedinbiopsyspecimensofpulmonaryepitheliumdescribed
to be preneoplastic lesions.
1.Background
Cigarette smoking is a major cause of lung cancer. 90% of
male and 75–80% of female lung cancer deaths in the USA
are smoking related [1]. As deﬁned by the International
Agency for Research on Cancer (IARC), each cigarette
contains a mixture of more than 60 known carcinogens [2].
At least twenty of these carcinogens have been linked to
tumors [1].
Bronchial epithelium undergoes a stepwise preneoplastic
process encompassing various morphological and molecular
changes before overt development of lung cancer [3]. The 5-
year survival for patients with lung cancer is approximately
15% [4], and patients with nonsmall cell lung cancer in stage
I-A disease have a 33% chance of recurrence within 5 years
a f t e rc o m p l e t es u r g i c a lr e s e c t i o n[ 5, 6]. Currently, there is no
immunohistochemical or morphological marker, available
for metaplasia, dysplasia, or carcinoma insitu, which reliably
predicts the biological behavior of preneoplastic lesions.
The BCL-2 [7–9]a n dBCL2L1 antiapoptotic genes are
expected to contribute to carcinogenesis. BCL-2 prolongs
survival of noncycling cells and inhibits apoptosis of cycling2 Journal of Oncology
cells [10, 11]. Epidermal growth factor receptor (EGFR)i s
a tyrosine kinase receptor which increased cell proliferation
[12–16]. BIRC5 is a member of the inhibitor of apoptosis
protein (IAP) family, a cell-cycle-regulated bifunctional
protein expressed in G2/M phase [17–19]. BIRC5 may
overcome G2/M phase checkpoints to enforce progression
of cells through mitosis, favoring development of neoplastic
clones. MKI67 is expressed during all active phases of the cell
cycle. The fraction of MKI67-positive tumor cells (MKI67
labeling index) provides correlation with the clinical course
of disease [20–22].
While malignant transformation can be induced in
bronchial epithelial cell cultures, the eﬀects of exposure to
individual tobacco carcinogens have not been well studied
during phases preceding the development of overt cancer.
The purpose of our current work is to study the eﬀect of
individualtobaccocarcinogensonculturedhumanbronchial
epithelial cells.
2.MaterialsandMethods
2.1. Reagents. Sources of the toxins, cell line, antibodies,
and reagents used in this work are listed in supplementary
data (see the Supplementary Material available online at
doi:10.1155/2011/208563).
2.2. Cell Culture. Bronchial epithelial growth medium
(BEGM) was prepared as previously described [23]. The
cryopreserved cell line was thawed and initially grown in
35mm plastic dishes in the above-speciﬁed medium in
a humidiﬁed 5% CO2 incubator at 37◦C until cells were
70–80% conﬂuent. Cells were lifted by trypsinization and
replated in 24-well plates containing glass cover slips until
they are 70–80% conﬂuent.
2.3. Toxin Exposure. Toxin solutions (Table 1)w e r ee v a l -
uated for eﬀects on nonspeciﬁc esterase (NSE) and cyto-
morphology assessed by PAP staining and phase contrast
microscopy. We evaluated the eﬀects of nickel sulphate
(heavy metal), benzo(b)ﬂuoranthene (polyaromatic hydro-
carbon), N-nitrosodiethylamine (a tobacco nitrosamine),
and NNK (a nicotine derivative) using electron microscopy
and immunohistochemistry after 24 and 48 hours of expo-
sure at low carcinogen concentration. The ﬁnal concentra-
tion of solvents in the culture media was less than 0.01%
as previously described [24]. The working concentration of
toxinswerebasedontheepithelialexposuretotoxintypically
present in one cigarette [25]. The median concentration of
each toxin in one smoked cigarette was taken as the medium
concentration (M), and lower (L) and higher (H) dose expo-
sure concentrations were arbitrarily determined (Table 1).
Two controls were included with each carcinogen exposure,
a “solvent control” (S) corresponding to the solvent used to
dissolve the toxin (used equivalent to the highest concen-
tration) and a “negative control” (N) containing only the
growth medium. Cells were incubated in the culture media
containing toxins or controls for 24 and 48 hours. Cells were
then washed with DPBS. For Pap staining, cells were ﬁxed in
95% alcohol for 30 minutes, air-dried, and stored at 4◦C. For
electron microscopy, cells were trypsinized, washed twice in
growth medium and, centrifuged. The cell pellet was ﬁxed in
2.5% glutaraldehyde and refrigerated at 4◦C.
2.4. Nonspeciﬁc Esterase (NSE) Cytochemistry and Papanico-
laou (PAP) Staining. We used NSE staining as a measure
of cell activity and to determine the minimally toxic con-
centration of tested chemicals that is capable of inducing a
meaningful change in the cytomorphology. The staining was
done as previously described [26, 27]. The stained cells on
the cover slips were air-dried and mounted inverted on glass
slides using Permount mounting media (Fisher Scientiﬁc,
Pittsburgh, PA).
2.5.Immunohistochemistry(IHC). Fixedcytospinslideswere
incubated in 3% hydrogen peroxide for 15 minutes at
room temperature, rinsed in distilled water, incubated for
10–15 minutes at room temperature with blocking serum,
followed by the application of primary mouse monoclonal
antibodiesforEGFR(1:100),TP53(1:100),BIRC5(1:150),
MKI67 (1:50), BCL-2 (1:100), and BCL2L1 (1:150). The
primary antibodies were incubated for 60 minutes at room
temperature. The slides were washed three times with
PBS 0.2% Tween followed by application of biotin-labeled
antimouseIgGandfurtherincubatedfor30minutesatroom
temperature. The cells were then washed with PBS 0.2%
Tween, and a working dilution of fresh DAB solution was
added.SlideswerecounterstainedinfreshGill’shematoxylin,
placed in ammonia water for 5–10 seconds, dehydrated, and
mounted with Permount.
2.6. Electron Microscopy (EM). Standard tissue process-
ing for electron microscopy was used [28]. Toxin-treated
glutaraldehyde-ﬁxed cell pellets ware washed in Millonig’s
phosphate buﬀer and placed in 1% osmium tetroxide for
one hour, washed twice with Millonigs buﬀer, dehydrated
by passing through graded ethanol twice, 15 minutes each,
and ﬁnally left in 100% ethanol for 30 minutes. Then, the
pellet was treated with 1:1 and 3:1 working Spurr:ethanol
mixtures followed by a 100% working Spurr solution, 30
minutes each, and embedded in the center of a beam
capsule.Thickandthinsectionswerepreparedandexamined
with a transmission electron microscope (Tecnai 12 T; FEI
Company, Hillsboro, Oregon).
2.7. Phase Contrast Microscopy. All slides after deﬁned expo-
sure times and prior to any further processing were viewed
usinganinvertedphasecontrastmicroscope(LeicaDMIRE2,
Germany) at 20x, and appropriate images were taken.
Regular digital images of stained slides were taken at 60x for
morphometry using a microscope (Olympus BX51, Center
Valley, PA) ﬁtted with a digital camera (Olympus DP71,
Center Valley, PA). A bar of 100 microns was drawn using an
internal scale at 60x, later used to calibrate ImageJ software.
2.8. Evaluation of NSE, ki-67, p53 Staining, and Morphom-
etry. NSE staining was evaluated in 100 cells under 60x
objective. Negative cells were graded as zero, minimalJournal of Oncology 3
Table 1: Tobacco carcinogens and dilutions used.
No. Tobacco carcinogens Toxin range: ng/cigarette Working concentrations Solvent used for stock soln.
High ng/ml Med#ng/ml Lowng/ml
(1) Nickel Sulphate∗∗ 0–510 800 500 200 Water
(2) Cadmium Chloride 0–6670 1200 700 200 Water
(3) Chromium Chloride 0.2–500 800 500 200 Water
(4) Sodium Selenite 0–1400 1900 1400 900 Water
(5) Benzo(b)ﬂuoranthene∗∗ 4–22 44 22 2 Acetone
(6) Indeno(1,2,3,-d)pyrene 4–20 40 20 2 ETOH
(7) Ethyl Carbamate 20–38 80 40 2 ETOH
(8) Dibenz(a,h)anthracene∗ 4 12 4 1 Toluene
(9) N-Nitrosodiethylamine∗∗ 0–2.8 9 3 1 ETOH
(10) 5-Methylchrysene 0.6 3 1 0.25 ETOH
(11) Dibenzopyrene 1.7–3.2 9 3 1 ETOH
(12) Dibenz(a,h)acridine 0.1 3 0.1 0.25 Acetone
(13) NNK∗∗ 80–770 1300 800 300 Water
(14) Benzo(k)ﬂuoranthene∗ 6–12 24 12 2 Toluene
∗Excluded from morphometry and immunohistochemical analysis due to cytotoxicity.
∗∗Used in immunohistochemistry only.
#Equivalent volume of solvent/mL BEGM used as solvent (S) control in NSE staining only.
staining and/or forming an incomplete rim around the
nucleus whether punctate or homogeneous as 1, moderate
staining and/or forming a complete rim around the nucleus
whether punctate or homogeneous as 2, and strong staining
forming a complete rim around the nucleus as 3. Some
small pyknotic nonstaining cells, most probably representing
basal cells, identiﬁed both in the unexposed and exposed
cultures were not counted. For morphometry of cytological
eﬀects, nuclear:cytoplasmic ratios were determined with
NIH ImageJ software. Manual threshold of an 8-bit greyscale
image was performed and regions of interest were selected
with the “region of interest” (ROI) manager. A line-
drawing tool was used to select areas not amenable to
thresholding. ImageJ was calibrated in a set scale window
by using the 100µm scale bar captured earlier at 60x
magniﬁcation. For density calibration, ImageJ was calibrated
following the procedure listed at the HIN ImageJ manual
(http://rsb.info.nih.gov/ij/).Biostatisticalanalysisandgraph-
ical displays were done using R software (http://www.r-
project.org/).
3. Results
3.1. NSE, PAP Staining, and Morphometry. The morphology
of untreated cells was used as the basis for comparison.
Thesecellsdisplayedregularandsmoothcellularandnuclear
contours and small nucleoli. All carcinogen-treated cells
displayed a range of morphologic changes; a representative
image depicting benzo(b)ﬂuoranthene-treated cells is dis-
played in Figure 1 (top panel). At low concentration, cells
displayed nuclear enlargement, minimal to slight nuclear
contourirregularities, andenlargementofthenucleolus with
minimal changes in cell membrane outline. Additionally,
at medium concentration, cells demonstrated a mild to
moderate increase in nuclear density, a further increase in
nucleolarsize,shrinkingofcytoplasmicmembranes,changes
in cell size, and nuclear:cytoplasmic (N:C) ratio. At the
highest concentration, nuclear hyperchromasia increased
signiﬁcantly with marked nuclear contour irregularities
and inconspicuous nucleoli. A second population of large
atypical cells with irregular and folded nuclei emerged in
the exposed cultures constituting only 5–10% of the total
population. These large cell population were excluded from
the morphometric evaluation which showed that the N:C
ratios for seven of the carcinogen exposures (nickel sulphate,
chromium chloride, benzo(b)ﬂuoranthene, indeno(1,2,3,-
cd)pyrene, ethyl carbamate, N-nitrosodiethylamine, and
NNK) were statistically signiﬁcantly higher than controls at
diﬀerent carcinogen concentrations (Table 2). PAP-stained,
vehicle-treated cells did not show any of the morphological
changes described above (not shown). NSE staining was
consistently absent in all twelve toxin-exposed cell groups
at all concentrations with the exception of cadmium and
chromium chloride, which showed weak activity at low (L)
concentration. Intense peroxidase staining was observed in
medium only control cells (N). Cells incubated with solvents
(S) demonstrated NSE activity comparable to medium only
controls (Figure 1).
3.2. Phase Contrast Microscopy and Electron Microscopy. All
toxin-treated cell groups demonstrated shrinkage, small cell
size, and nuclear granularity with membrane irregularity
using phase contrast microscopy. A notable ﬁnding was
cytoplasmic blebbing and outpouching with loss of cell
membrane smoothness induced by N-nitrosodiethylamine
even at low concentration (Figure 2). Cells treated with
nickel sulphate, benzo(b)ﬂuoranthene, and NNK revealed
striking and consistent changes in the nucleoli by electron
microscopy. Nucleolar size increased markedly with changes
in shape including elongation, as well as multiple enlarged4 Journal of Oncology
Table 2: N:C ratios at 24-hour carcinogen exposure compared to vehicle controls.
Carcinogen N:C ratio at high dose N:C ratio at med dose N:C ratio at low dose
Nickel sulphate 0.338 (0.033) 0.318 (0.032) 0.196 (0.034)
P = .002 P = .017 P = .042
Chromium chloride 0.300 (0.031) 0.365 (0.033) 0.370 (0.033)
NS P<. 05 P<. 05
Benzo(b)ﬂuoranthene 0.360 (0.034) 0.242 (0.033) 0.253 (0.033)
P<. 05 NS NS
Indeno(1,2,3,-cd)pyrene 0.184 (0.046) 0.248 (0.033) 0.209 (0.034)
P = .03 NS NS
Ethyl carbamate 0.254 (0.029) 0.273 (0.028) 0.254 (0.028)
NS NS NS
N-Nitrosodiethylamine 0.285 (0.028) 0.276 (0.028) 0.214 (0.029)
NS NS NS
NNK 0.283 (0.032) 0.319 (0.035) 0.260 (0.032)
NS P = .009 NS
NS: not statistically signiﬁcant (P ≥ .05).
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Figure 1: (60x magniﬁcation) Top Panel: eﬀects of benzo(b)ﬂuoranthene on morphology assessed by Papanicolaou stain. Note changes
in cell size, nuclear size, nucleolar size, and nuclear and cytoplasmic density. Bottom Panel: histochemical staining for nonspeciﬁc esterase
(NSE) of control and benzo(b)ﬂuoranthene-treated cells. The negative (N) and solvent (S) controls (acetone exposure) display positive
perinuclear, punctuate, or Golgi pattern of dense NSE staining while benzo(b)ﬂuoranthene-exposed cells showed completely negative
staining at all exposure concentrations. N: negative control, S: solvent control, L: low carcinogen concentration, M: medium carcinogen
concentration, and H: high carcinogen concentration.
and/or irregularly shaped nucleoli. In some cells, the nucle-
olus appeared to span the inner diameter of the nucleus.
Electron dense nonmembrane bound granular material was
occasionally noted in the cytoplasm of cells not treated with
toxins (Figure 3).
3.3. Immunohistochemistry. Negative control cells (media
only or solvent) showed absent staining for all antibodies
except membrane staining for EGFR (Figure 4). By omitting
the primary antibody, “negative immunostaining controls”
were also evaluated, none of which showed any staining
(not shown). BCL-2 staining at 24-hr exposure was negative
in all cells except large atypical cells with multiple and
irregular nuclei showing BCL-2 localized to their nuclei
with weak to moderate cytoplasmic staining. Cells with
pyknotic and shrunken nuclei and those undergoing mitosis
demonstrated strong nuclear positivity. These changes were
consistent among all four toxins tested at both 24 and 48
hours; however, a few large atypical cells were positive at
48 hrs for BCL-2. MKI67 was not evaluated at 48 hours.
At 24-hour exposure, MKI67 showed high reactivity in a
speckled and granular pattern outlining the chromatin. In
stark contrast to BCL-2, MKI67 did not stain large atypical
cells with irregular and multiple nuclei. Twenty large atypicalJournal of Oncology 5
Table 3: Percent staining of MKI67 in cultures exposed for 24 hours. All values expressed as percentages.
MKI67 Percent (%)
Positive small cells Negative small cells Positive large cells Negative large cells
Nickel sulphate 93.6 6.3 0 20
Benzo(b)ﬂuoranthene 92.6 7.3 0.3 19.6
N-nitrosodiethylamine 78 22 1 19
NNK 84.3 15.6 1 19
Table 4: Percent staining for TP53-positive cells.
TP53 Percent (%)
Positive small cells Negative small cells Positive large cells Negative large cells
Nickel sulphate 24hr 98.3 1.6 19 1
Nickel sulphate 48hr 95.6 4.3 20 0
Benzo(b)ﬂuoranthene 24hr 68 32 19.3 0.6
Benzo(b)ﬂuoranthene 48hr 82.6 17.3 17.3 2.6
N-nitrosodiethylamine 24hr 82.3 27.6 17.3 2.6
N-nitrosodiethylamine 48hr 64.6 35.3 17.6 2.3
NNK 24hr 92 8 17.6 2.3
NNK 48hr 98.6 1.3 19.6 0.3
All values expressed as percentages.
Figure 2: Although seen with many carcinogen exposures as
occasional ﬁnding at higher concentrations, striking blebbing
of the cytoplasmic membrane was noted with 24-hour N-nitro-
sodiethylamine exposure at extremely low concentration (1 ng/mL)
detected by phase contrast microscopy at 60x. Inset: negative
control as comparison with smooth and regular cell surface.
cellnuclei and 100 small-cellnuclei werecounted three times
and the average number of nuclei which were positively
stained for MKI67 was represented as a percentage of the
total (Table 3). A similar approach was used to assess nuclear
TP53 staining in both small and large atypical cells (Table 4).
Small cells stained positive while large cells were predom-
inantly negative. In cells exposed to benzo(b)ﬂuoranthene
the number of TP53 positive cells increased from 68% to
82.6% at the 24- versus 48-hour exposure interval. With N-
nitrosodiethylamine, immunostaining for TP53 was positive
in a greater proportion of cells (82.3%) at 24 hours (82.3%
versus 64.6%). Staining pattern of TP53 remained the same
at 24- and 48-hour exposures in the large atypical cells. At
24 hour exposure, EGFR demonstrated strong cytoplasmic
and cell membrane staining and very weak nuclear staining
in all cells. At 48-hour exposure, only nuclei of small
cells stained strongly positive with no cytoplasmic or cell
membrane staining. The large atypical cells with multiple
irregular nuclei were mostly negative with occasional cells
demonstrating weak and variable EGFR staining in the
cytoplasm and/or nucleus. For all four toxins tested at
24- and 48-hour exposures, BIRC5 activity was distributed
primarily in the cytoplasm of cells, although some nuclear
staining wasalsoobserved incellsexposed tonickel sulphate.
Relatively stronger nuclear staining for BIRC5 was noted
in large atypical cells with irregular nuclei. At the 48-hour
exposure, only cytoplasmic staining was observed in small
and large cells. Some membranous staining in cells exposed
to benzo(b)ﬂuoranthene was noted. BCL2L1 staining was
present in both the cytoplasm and nucleus of the cells at 24-
and48-hourexposure.BCL2L1wasmorestronglypositivein
benzo(b)ﬂuoranthene compared to nickel sulphate exposed
c e l l sa t2 4h o u r s( Figure 4). In general, there was no
diﬀerence in cell viability between toxin treated cells and
control cells (data not shown).
4. Discussion
In this study we have developed a reproducible technique
for exposing human bronchial epithelial cells in culture to6 Journal of Oncology
Nickel sulfate (L) NNK (L)
NNK (L) NNK (L) Negative
Benzo(b)ﬂuoranthene (H)
Figure 3: Electron microscopy shows striking and consistent nuclear and nucleolar changes with markedly increased size and changes in
shape including elongation and multiple enlarged and/or irregularly shaped nucleoli and nucleolus appearing to span the inner diameter of
the nucleus. The electron dense cytoplasmic granular material is present only in the negative control. NNK is represented in multiple images
to show the pleomorphism in the toxin-induced nuclear changes. Direct magniﬁcation: 6500x, Print magniﬁcation: 11200x at 7 inch.
soluble tobacco toxins and have observed the early eﬀects of
these toxins on cell morphology, NSE activity, and selected
gene expression. Although the immunohistochemical pro-
ﬁle of various proteins in invasive lung carcinomas has
been extensively studied, there are relatively few studies of
protein expression in precancerous lesions [29], and virtu-
ally no information on the changes in cultured bronchial
epithelial cells after toxin exposure. Among tobacco toxins
benzo(a)pyrene (BaP), a prototypic polyaromatic hydrocar-
bon (PAH), has perhaps been the most extensively studied.
The unique eﬀects of other toxins are less well recog-
nized in the complex composite milieu of tobacco smoke
exposure experiments. There is limited data on exposure
levels of individual tobacco toxins [30–36]. Accordingly,
w ec h o s ear a n g eo fe x p o s u r ec o n c e n t r a t i o n sb a s e do nt h e
reported concentration of toxins found in a smoked cigarette
[25]. In our experiments, cells were exposed for 24 and
48 hours, allowing adequate time for protein synthesis.
Dibenz(a,h)anthracene and benzo(k)ﬂuoranthene, which
weresolubleonlyintoluene,wereexcludedfromouranalysis
to avoid the confounding issue of toluene cytotoxicity.
After exposure to toxins, cells displayed a spectrum of
morphologic changes including nuclear enlargement and
contour irregularities, enlargement of nucleoli, increase
in nuclear density, shrinking of cytoplasmic membrane,
changes in cell size, and N:C ratio, progressively accentuat-
ing from low to higher concentrations. In the exposed cell
cultures, there emerged a second population of abnormal
large atypical cells with very irregular and folded nuclei
constituting 5–10% of the cellular population. All these fea-
tures resemble those which characterize dysplastic cells. Our
results further indicate a consistent decrease in NSE in toxin-
treated cells relative to the controls for all tobacco toxins.
EGFR is overexpressed in human cancer cells and is
linked to metastasis and resistance to treatment. In our
study, EGFR was strongly positive in the cell membrane and
cytoplasm with only weak nuclear staining following a 24-
hour toxin exposure. After 48 hours of exposure, all EGFR
staining was concentrated in the nucleus. The nonexposed
cells showed only indistinct membranous rim-like staining.
Immunostaining for EGFR has been shown to increase with
the severity of dysplasia in preneoplastic and early neoplastic
bronchial epithelium. Conversely, decreased expression of
EGFR follows regression of bronchial squamous metaplasia
[13, 16, 19, 29]. The nuclear shift of EGFR after a 48-
hour toxin exposure correlates with the observation that, in
response to growth factor stimulation, a fraction of EGFR
moves from the cell surface to the nucleus, possibly inter-
acting with STAT3 and directly regulating gene expression
[15].Journal of Oncology 7
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Figure 4: Immunostaining for BCL-2, EGFR, Ki-67, BCL-XL, p53, and BIRC5 after 24-hr (rows 1 and 3) and 48-hr (rows 2 and 4) exposure
to benzo(b)ﬂuoranthene at low concentration. Original magniﬁcation 60x. (a) BCL-2. Only nuclei of large atypical cells stain positively
for BCL-2 at 24-hour exposure; staining is decreased slightly at 48-hour exposure. Inset: A pyknotic cell (top) and mitotic ﬁgure (bottom)
stain strongly for Bcl-2. (b) EGFR. EGFR localized to cell membrane, cytoplasm, and weakly to nuclei of all cells at 24-hour exposure;
staining shifts to the nuclei at 48-hour exposure, strongly in small cells and weakly in large atypical cells. (c) MKI67, assessed at 24-hr
exposure only, strongly stained small cell nuclei with negative staining in large cells. (d) Negative control. Representative image of absence
of immunoperoxidase staining. (e) BCL2L1 Similar cytoplasmic and nuclear staining at both 24- and 48-hour exposure. F. TP53. Nuclear
staining is noted in nearly all cells at 24-hour exposure, with increased intensity at 48-hour exposure. (g) BIRC5 staining is localized mainly
in the cytoplasm of cells following the 24-hour exposure with relatively stronger nuclear staining in large atypical cells. At 48-hour exposure,
only cytoplasmic staining is observed with focal membranous staining.8 Journal of Oncology
BCL-2 expression has been seen in less aggressive tumor
behavior and is linked to increased cell survival [7]. Our
results indicate absent immunostaining for BCL-2 in the
majority of cells exposed to toxins for 24 or 48 hours.
However, the subpopulation of large atypical cells with
irregular and large nuclei demonstrates positive nuclear and
weakcytoplasmicBCL-2staining at24 hourswhichpersisted
with decreased intensity at 48-hrs. In the unexposed cells,
BCL-2 staining was undetectable. Reported studies in tissue
sections show basal BCL-2 staining in normal epithelium,
basal and suprabasal staining in metaplastic epithelium,
and increasingly aberrant BCL-2 expression with increasing
grades of dysplasia [7–9]. Substantial pools of BCL-2 have
been identiﬁed within interphase nuclei controlling cellular
proliferation that may induce rather than protect cells from
apoptosis [8, 37]. Our results also suggest that BCL-2 is
expressed early after toxin exposure.
The fact that MKI67 is present during all active phases
of the cell cycle and undetectable in resting cells makes it
an excellent marker for determining the growth fraction of a
given cell population [22]. We found high MKI67 immunos-
taining both speckled and granular patterns, outlining the
nuclear chromatin material of toxin-exposed cells (Table 3).
In contrast to BCL-2, immunostaining for MKI67 was not
seen in the population of large atypical cells with multiple
or irregular nuclei. MKI67 was completely absent in all cells
in the unexposed cultures. Various studies have reported
high MKI67 activity in bronchial dysplastic lesions including
62.5–100%byWangetal.[36],1to60%byTanetal.[20,36],
and 49% expression in small cell lung cancer specimens by
Paik et al. [36,38].OurﬁndingofhighMKI67 immunostain-
ing in toxin-exposed cells is therefore similar to observations
reported in tissue sections from dysplastic lesions.
S t u d i e sh a v er e p o r t e dn e g a t i v eBIRC5 staining in normal
bronchial epithelium, minimally atypical hyperplastic, and
nonneoplastic lesions adjacent to tumors. Both nuclear
and/or cytoplasmic BIRC5 expression has been identiﬁed
in metaplastic, dysplastic, and hyperplastic lesions with
moderate dysplasia [18, 36]. The level of BIRC5 correlates
with the degree of dysplasia and is highest in carcinomas
[19, 36]. BIRC5 was found to be localized to the nucleus in
70%ofearlyNSCLC’sandbothinthecytoplasmandnucleus
in 54% of cases. Moreover, it was also identiﬁed in atypical
mitotic ﬁgures and in giant multilobed neoplastic nuclei
[39]. We observed BIRC5 mainly in the cytoplasm of cells
following the 24-hour exposure, with some nuclear staining
in cells exposed to nickel sulphate and relatively stronger
nuclear BIRC5 in large atypical cells with irregular nuclei.
After 48-hour exposure, only cytoplasmic staining was
observed, with focal membranous staining in cells exposed
to benzo(b)ﬂuoranthene. This pattern in cultured bronchial
cells of persistent cytoplasmic BIRC5 immuno-reactivity
and minimal nuclear reactivity after 48 hours of exposure
to toxins somewhat diﬀers from other tissue-based studies
in which a predominance of nuclear immuno-reactivity has
been reported. This discrepancy may relate to the short time
interval of toxin exposure in our cell culture model or to
the combination eﬀect of multitoxin exposure in previous
studies.
In our study, strong TP53 nuclear staining was noted in
the cells exposed to some toxins for 24 hours which further
increased after 48 hours (Table 4). The variation of response
kinetics to diﬀerent toxins could be a reﬂection of a diﬀerent
mechanism of stimulating TP53. Altering signaling pathway
through protein phosphorylation or direct modiﬁcation of
intermediate signaling compounds is usually very fast. On
the other hand, alteration of mRNA expression or stability
takes a longer time, albeit shorter than an epigenetic modi-
ﬁcation. In nature, the half-life of these compounds is long
(2–>300 days). However, the half-life of these compounds
was never examined in tissue culture. In the control cultures,
only rare small cells showed positive TP53 staining. Several
studies demonstrate suppression of BIRC5 by TP53 [17].
The TP53 immunostaining is reported to be infrequent in
normal or metaplastic mucosa but may be seen in as many
as 30% of cases of mild bronchial epithelial dysplasia [36].
Progressively increased suprabasal expression of TP53 can be
seen with increasing grades of dysplasia. The likelihood of
invasive cancer has been positively correlated with the degree
of TP53 expression in bronchial epithelium from the same
lung lobe [40], suggesting that TP53 may have predictive
value in assessing the biological behavior of preneoplastic
endobronchiallesions.Inanotherstudy,41%ofpatientswith
dysplastic lesions showing >10% TP53-positive nuclei later
developedlungcancerwhereasonly23%ofthosewithTP53-
negative lesions progressed to cancer (positive and negative
predictive value of 78% and 77%, resp.) [41]. Our results
showthatexposuretotobaccotoxinsresultsinappearanceof
signiﬁcant TP53 nuclear immuno-reactivity compared with
unexposed (control) cells, and that the intensity of staining
increases with the duration of exposure to tobacco toxins.
There is little information in the literature on the
expression of BCL2L1 in preneoplastic/dysplastic pulmonary
lesions. Cytoplasmic expression of BCL2L1 and elevated
BCL2L1 gene transcripts have been reported in 81.7% and
60% of lung cancers, respectively. Patients with tumors
expressing BCL2L1 showed shorter median survival com-
pared to patients without BCL2L1-expressing tumors [11].
Either cytoplasmic or nuclear expression of BCL2L1 was
found in 81.5% and 30.4% of lung cancers, respectively.
Nuclear BCL2L1 expression correlated among all histologic
typeswithTNMstageIVandthehighexpressionofcytoplas-
mic BCL2L1 (81.9%) in resected non-small cell lung cancers
without any apparent inﬂuence on clinical outcome [10]. In
our study, both cytoplasmic and nuclear BCL2L1 staining
was present at 24- and 48-hour exposure intervals. BCL2L1
wasmorestronglypositiveinbenzo(b)ﬂuoranthene,exposed
cells compared to nickel-sulphate-treated cells at 24 hours,
suggesting that BCL2L1 expression may be toxin dependent.
In summary, our studies describe the eﬀects of known
pulmonary tobacco toxins on an established cell line of
humanbronchialepithelialcells.Althoughtheconcentration
of these toxins in cigarette smoke has been determined, we
could only estimate the appropriate concentration for
application to cells in tissue culture. Under the conditions
of our experiments, we found that a brief exposure of cells
to tobacco toxins produces consistent and reproducible
morphologic changes of cell and nuclear size and shape.Journal of Oncology 9
Using immunohistochemistry we found that cells treated
with toxins showed emergence of activities of EGFR, BCL-2,
MKI67, BCL2L1, BIRC5, and TP53 not found in untreated
control cells. These changes are similar to those reported in
tissue specimens of preneoplastic lesions and fully developed
lung cancer. The ﬁndings of this study suggest that changes
in expression of these proteins occur at a rapid rate after
exposure of the cells to toxins, raising the possibility that
some changes associated with overt malignancy might
occur rapidly in vivo following toxin exposure. Prolonged
or intermittent toxin exposure eﬀect on cells is not known.
Additional studies using human bronchial epithelial cell
lines with other toxins or chronic intermittent exposure
might increase our understanding of pathways involved in
the development of lung cancer.
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